Concepedia
Statistics
Publications
8
Citations
327
H-Index
Active since
2003
Affiliations
AstraZeneca (Sweden)(Current)
KTH Royal Institute of Technology
Jan Blid is an author at AstraZeneca (Sweden) specializing in chemistry, organic chemistry, and natural sciences.
Publications per year
2003–2017
Competing Pathways in O‐Arylations with Diaryliodonium Salts: Mechanistic Insights
Elin Stridfeldt, Erik Lindstedt, Marcus Reitti et al. · Chemistry - A European Journal · 2017 · 78 citations · Full text
Natural Sciences, Chemistry, Computational Chemistry +15
New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain
Ylva Gravenfors, Jenny Viklund, Jan Blid et al. · Journal of Medicinal Chemistry · 2012 · 65 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
Asymmetric [2,3]-Sigmatropic Rearrangement of Allylic Ammonium Ylides
Jan Blid, Olaf Panknin, Peter Somfai · Journal of the American Chemical Society · 2005 · 50 citations · Full text
Natural Sciences, Chemistry, Organic Chemistry +10
Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity
Tobias Ginman, Jenny Viklund, Jonas Malmström et al. · Journal of Medicinal Chemistry · 2012 · 40 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Lewis Acid Mediated [2,3]-Sigmatropic Rearrangement of Allylic <i>α</i>-Amino Amides
Jan Blid, Peter Brandt, Peter Somfai · The Journal of Organic Chemistry · 2004 · 37 citations
Natural Sciences, Chemistry, Computational Chemistry +12
1–5 of 8